InnoCare Pharma Limited (HKG:9969)
Hong Kong
· Delayed Price · Currency is HKD 14.36
-0.08 (-0.55%)
At close: Dec 5, 2025
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 27.88 billion as of December 5, 2025. Its market cap has increased by 106.81% in one year.
Market Cap
27.88B
Enterprise Value
22.05B
Revenue
1.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.36
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 27.88B, an increase of 127.10%. That is a compound annual growth rate of 15.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 27.88B | 128.18% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | 17.38B | 41.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.02B |
| Hansoh Pharmaceutical Group Company | 243.25B |
| JD Health International | 192.57B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 135.64B |
| Sino Biopharmaceutical | 122.99B |
| Akeso | 113.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 100.74B |